Click for best price
Diabetes Mellitus Drugs Market Size, Share 2023
Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia.High blood sugar is caused by defective secretion of insulin or impaired biological function, or both.Long-term hyperglycemia leads to chronic damage and dysfunction of various tissues, especially eyes, kidneys, heart, blood vessels and nerves.
This report aims to provide a comprehensive presentation of the global market for Diabetes Mellitus Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Mellitus Drugs. This report contains market size and forecasts of Diabetes Mellitus Drugs in global, including the following market information:
Global Diabetes Mellitus Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Diabetes Mellitus Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oral Medicine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Diabetes Mellitus Drugs include Novo Nordisk, Merck & Co, Boehringer Ingelheim, AstraZeneca, Eli Lilly and Company, Johnson & Johnson, Takeda, Sanofi and Gan & Lee Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetes Mellitus Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Mellitus Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Diabetes Mellitus Drugs Market Segment Percentages, by Type, 2022 (%)
Oral Medicine
Injection Medicine
Global Diabetes Mellitus Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Diabetes Mellitus Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Diabetes Mellitus Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Diabetes Mellitus Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Mellitus Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Diabetes Mellitus Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Merck & Co
Boehringer Ingelheim
AstraZeneca
Eli Lilly and Company
Johnson & Johnson
Takeda
Sanofi
Gan & Lee Pharmaceuticals
Bayer
Tonghua Dongbao Pharmaceutical Co
Huadong Medicine
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diabetes Mellitus Drugs, market overview.
Chapter 2: Global Diabetes Mellitus Drugs market size in revenue.
Chapter 3: Detailed analysis of Diabetes Mellitus Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diabetes Mellitus Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Diabetes Mellitus Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Diabetes Mellitus Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetes Mellitus Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diabetes Mellitus Drugs Overall Market Size
2.1 Global Diabetes Mellitus Drugs Market Size: 2022 VS 2029
2.2 Global Diabetes Mellitus Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Diabetes Mellitus Drugs Players in Global Market
3.2 Top Global Diabetes Mellitus Drugs Companies Ranked by Revenue
3.3 Global Diabetes Mellitus Drugs Revenue by Companies
3.4 Top 3 and Top 5 Diabetes Mellitus Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Diabetes Mellitus Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetes Mellitus Drugs Players in Global Market
3.6.1 List of Global Tier 1 Diabetes Mellitus Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetes Mellitus Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Diabetes Mellitus Drugs Market Size Markets, 2022 & 2029
4.1.2 Oral Medicine
4.1.3 Injection Medicine
4.2 By Type - Global Diabetes Mellitus Drugs Revenue & Forecasts
4.2.1 By Type - Global Diabetes Mellitus Drugs Revenue, 2018-2023
4.2.2 By Type - Global Diabetes Mellitus Drugs Revenue, 2024-2029
4.2.3 By Type - Global Diabetes Mellitus Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diabetes Mellitus Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Diabetes Mellitus Drugs Revenue & Forecasts
5.2.1 By Application - Global Diabetes Mellitus Drugs Revenue, 2018-2023
5.2.2 By Application - Global Diabetes Mellitus Drugs Revenue, 2024-2029
5.2.3 By Application - Global Diabetes Mellitus Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Diabetes Mellitus Drugs Market Size, 2022 & 2029
6.2 By Region - Global Diabetes Mellitus Drugs Revenue & Forecasts
6.2.1 By Region - Global Diabetes Mellitus Drugs Revenue, 2018-2023
6.2.2 By Region - Global Diabetes Mellitus Drugs Revenue, 2024-2029
6.2.3 By Region - Global Diabetes Mellitus Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Diabetes Mellitus Drugs Revenue, 2018-2029
6.3.2 US Diabetes Mellitus Drugs Market Size, 2018-2029
6.3.3 Canada Diabetes Mellitus Drugs Market Size, 2018-2029
6.3.4 Mexico Diabetes Mellitus Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Diabetes Mellitus Drugs Revenue, 2018-2029
6.4.2 Germany Diabetes Mellitus Drugs Market Size, 2018-2029
6.4.3 France Diabetes Mellitus Drugs Market Size, 2018-2029
6.4.4 U.K. Diabetes Mellitus Drugs Market Size, 2018-2029
6.4.5 Italy Diabetes Mellitus Drugs Market Size, 2018-2029
6.4.6 Russia Diabetes Mellitus Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Diabetes Mellitus Drugs Market Size, 2018-2029
6.4.8 Benelux Diabetes Mellitus Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Diabetes Mellitus Drugs Revenue, 2018-2029
6.5.2 China Diabetes Mellitus Drugs Market Size, 2018-2029
6.5.3 Japan Diabetes Mellitus Drugs Market Size, 2018-2029
6.5.4 South Korea Diabetes Mellitus Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Diabetes Mellitus Drugs Market Size, 2018-2029
6.5.6 India Diabetes Mellitus Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Diabetes Mellitus Drugs Revenue, 2018-2029
6.6.2 Brazil Diabetes Mellitus Drugs Market Size, 2018-2029
6.6.3 Argentina Diabetes Mellitus Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetes Mellitus Drugs Revenue, 2018-2029
6.7.2 Turkey Diabetes Mellitus Drugs Market Size, 2018-2029
6.7.3 Israel Diabetes Mellitus Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Diabetes Mellitus Drugs Market Size, 2018-2029
6.7.5 UAE Diabetes Mellitus Drugs Market Size, 2018-2029
7 Diabetes Mellitus Drugs Companies Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Company Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Diabetes Mellitus Drugs Major Product Offerings
7.1.4 Novo Nordisk Diabetes Mellitus Drugs Revenue in Global Market (2018-2023)
7.1.5 Novo Nordisk Key News & Latest Developments
7.2 Merck & Co
7.2.1 Merck & Co Company Summary
7.2.2 Merck & Co Business Overview
7.2.3 Merck & Co Diabetes Mellitus Drugs Major Product Offerings
7.2.4 Merck & Co Diabetes Mellitus Drugs Revenue in Global Market (2018-2023)
7.2.5 Merck & Co Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Diabetes Mellitus Drugs Major Product Offerings
7.3.4 Boehringer Ingelheim Diabetes Mellitus Drugs Revenue in Global Market (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Diabetes Mellitus Drugs Major Product Offerings
7.4.4 AstraZeneca Diabetes Mellitus Drugs Revenue in Global Market (2018-2023)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Company Summary
7.5.2 Eli Lilly and Company Business Overview
7.5.3 Eli Lilly and Company Diabetes Mellitus Drugs Major Product Offerings
7.5.4 Eli Lilly and Company Diabetes Mellitus Drugs Revenue in Global Market (2018-2023)
7.5.5 Eli Lilly and Company Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Diabetes Mellitus Drugs Major Product Offerings
7.6.4 Johnson & Johnson Diabetes Mellitus Drugs Revenue in Global Market (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Takeda
7.7.1 Takeda Company Summary
7.7.2 Takeda Business Overview
7.7.3 Takeda Diabetes Mellitus Drugs Major Product Offerings
7.7.4 Takeda Diabetes Mellitus Drugs Revenue in Global Market (2018-2023)
7.7.5 Takeda Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Diabetes Mellitus Drugs Major Product Offerings
7.8.4 Sanofi Diabetes Mellitus Drugs Revenue in Global Market (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
7.9 Gan & Lee Pharmaceuticals
7.9.1 Gan & Lee Pharmaceuticals Company Summary
7.9.2 Gan & Lee Pharmaceuticals Business Overview
7.9.3 Gan & Lee Pharmaceuticals Diabetes Mellitus Drugs Major Product Offerings
7.9.4 Gan & Lee Pharmaceuticals Diabetes Mellitus Drugs Revenue in Global Market (2018-2023)
7.9.5 Gan & Lee Pharmaceuticals Key News & Latest Developments
7.10 Bayer
7.10.1 Bayer Company Summary
7.10.2 Bayer Business Overview
7.10.3 Bayer Diabetes Mellitus Drugs Major Product Offerings
7.10.4 Bayer Diabetes Mellitus Drugs Revenue in Global Market (2018-2023)
7.10.5 Bayer Key News & Latest Developments
7.11 Tonghua Dongbao Pharmaceutical Co
7.11.1 Tonghua Dongbao Pharmaceutical Co Company Summary
7.11.2 Tonghua Dongbao Pharmaceutical Co Business Overview
7.11.3 Tonghua Dongbao Pharmaceutical Co Diabetes Mellitus Drugs Major Product Offerings
7.11.4 Tonghua Dongbao Pharmaceutical Co Diabetes Mellitus Drugs Revenue in Global Market (2018-2023)
7.11.5 Tonghua Dongbao Pharmaceutical Co Key News & Latest Developments
7.12 Huadong Medicine
7.12.1 Huadong Medicine Company Summary
7.12.2 Huadong Medicine Business Overview
7.12.3 Huadong Medicine Diabetes Mellitus Drugs Major Product Offerings
7.12.4 Huadong Medicine Diabetes Mellitus Drugs Revenue in Global Market (2018-2023)
7.12.5 Huadong Medicine Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Diabetes Mellitus Drugs Market Opportunities & Trends in Global Market
Table 2. Diabetes Mellitus Drugs Market Drivers in Global Market
Table 3. Diabetes Mellitus Drugs Market Restraints in Global Market
Table 4. Key Players of Diabetes Mellitus Drugs in Global Market
Table 5. Top Diabetes Mellitus Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Diabetes Mellitus Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Diabetes Mellitus Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Diabetes Mellitus Drugs Product Type
Table 9. List of Global Tier 1 Diabetes Mellitus Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetes Mellitus Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Diabetes Mellitus Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Diabetes Mellitus Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Diabetes Mellitus Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Diabetes Mellitus Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Diabetes Mellitus Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Diabetes Mellitus Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Diabetes Mellitus Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Diabetes Mellitus Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Diabetes Mellitus Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Diabetes Mellitus Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Diabetes Mellitus Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Diabetes Mellitus Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Diabetes Mellitus Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Diabetes Mellitus Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Novo Nordisk Company Summary
Table 31. Novo Nordisk Diabetes Mellitus Drugs Product Offerings
Table 32. Novo Nordisk Diabetes Mellitus Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Novo Nordisk Key News & Latest Developments
Table 34. Merck & Co Company Summary
Table 35. Merck & Co Diabetes Mellitus Drugs Product Offerings
Table 36. Merck & Co Diabetes Mellitus Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Merck & Co Key News & Latest Developments
Table 38. Boehringer Ingelheim Company Summary
Table 39. Boehringer Ingelheim Diabetes Mellitus Drugs Product Offerings
Table 40. Boehringer Ingelheim Diabetes Mellitus Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Boehringer Ingelheim Key News & Latest Developments
Table 42. AstraZeneca Company Summary
Table 43. AstraZeneca Diabetes Mellitus Drugs Product Offerings
Table 44. AstraZeneca Diabetes Mellitus Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. AstraZeneca Key News & Latest Developments
Table 46. Eli Lilly and Company Company Summary
Table 47. Eli Lilly and Company Diabetes Mellitus Drugs Product Offerings
Table 48. Eli Lilly and Company Diabetes Mellitus Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Eli Lilly and Company Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Diabetes Mellitus Drugs Product Offerings
Table 52. Johnson & Johnson Diabetes Mellitus Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Takeda Company Summary
Table 55. Takeda Diabetes Mellitus Drugs Product Offerings
Table 56. Takeda Diabetes Mellitus Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Takeda Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Diabetes Mellitus Drugs Product Offerings
Table 60. Sanofi Diabetes Mellitus Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Gan & Lee Pharmaceuticals Company Summary
Table 63. Gan & Lee Pharmaceuticals Diabetes Mellitus Drugs Product Offerings
Table 64. Gan & Lee Pharmaceuticals Diabetes Mellitus Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Gan & Lee Pharmaceuticals Key News & Latest Developments
Table 66. Bayer Company Summary
Table 67. Bayer Diabetes Mellitus Drugs Product Offerings
Table 68. Bayer Diabetes Mellitus Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Bayer Key News & Latest Developments
Table 70. Tonghua Dongbao Pharmaceutical Co Company Summary
Table 71. Tonghua Dongbao Pharmaceutical Co Diabetes Mellitus Drugs Product Offerings
Table 72. Tonghua Dongbao Pharmaceutical Co Diabetes Mellitus Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Tonghua Dongbao Pharmaceutical Co Key News & Latest Developments
Table 74. Huadong Medicine Company Summary
Table 75. Huadong Medicine Diabetes Mellitus Drugs Product Offerings
Table 76. Huadong Medicine Diabetes Mellitus Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Huadong Medicine Key News & Latest Developments
List of Figures
Figure 1. Diabetes Mellitus Drugs Segment by Type in 2022
Figure 2. Diabetes Mellitus Drugs Segment by Application in 2022
Figure 3. Global Diabetes Mellitus Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Diabetes Mellitus Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Diabetes Mellitus Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetes Mellitus Drugs Revenue in 2022
Figure 8. By Type - Global Diabetes Mellitus Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Diabetes Mellitus Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Diabetes Mellitus Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Diabetes Mellitus Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Diabetes Mellitus Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Diabetes Mellitus Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Diabetes Mellitus Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Diabetes Mellitus Drugs Revenue Market Share, 2018-2029
Figure 16. US Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Diabetes Mellitus Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Diabetes Mellitus Drugs Revenue Market Share, 2018-2029
Figure 28. China Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Diabetes Mellitus Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Diabetes Mellitus Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Diabetes Mellitus Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Novo Nordisk Diabetes Mellitus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck & Co Diabetes Mellitus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Boehringer Ingelheim Diabetes Mellitus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. AstraZeneca Diabetes Mellitus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Eli Lilly and Company Diabetes Mellitus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Johnson & Johnson Diabetes Mellitus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Takeda Diabetes Mellitus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sanofi Diabetes Mellitus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Gan & Lee Pharmaceuticals Diabetes Mellitus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bayer Diabetes Mellitus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Tonghua Dongbao Pharmaceutical Co Diabetes Mellitus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Huadong Medicine Diabetes Mellitus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
